Organisation paid for research Program year 2025 Source: CMS Open Payments

Evergreen Health

Neither a doctor nor a teaching hospital

Research payments

$502,454

249 payments

Through program year 2025, Evergreen Health is reported as receiving $502,454 in research payments, across 249 payments.

By program year

6 rows

Year	Kind	Amount	Payments
2025	Research	$61,241	1
2024	Research	$60,761	1
2022	Research	$2,046	4
2021	Research	$11,395	33
2020	Research	$123,749	34
2019	Research	$243,262	176

Breakdown

Who paid Research payments · program years 2019–2025

Merck Sharp & Dohme Corporation $263,325 6 payments
AbbVie, Inc. $161,472 28 payments
Boston Scientific Corporation $66,462 209 payments
Celgene Corporation $6,540 1 payment
Endologix, Inc. $4,655 5 payments

Studies the money was for Research payments · program years 2019–2025

A Randomized, Double-Blind, Placebo-Controlled, Crossover Pilot Study of Suvorexant for Insomnia in Parkinson Disease $144,307 3 payments
M15-741 $71,876 9 payments
DREAM: A Double-blind, CrossoveR, placebo-controlled Study to compare the Effects of Nighttime Administration of suvorexant in Patients with Multiple Sclerosis fatigue and insomnia $61,241 1 payment
A Double-blind, Crossover, Placebo-controlled Study to Compare the Effects of Nighttime Administration of Suvorexant in Patients with Multiple Sclerosis Fatigue and Insomnia $57,777 2 payments
M14-397 $45,735 8 payments
Combo $42,928 97 payments
M18-918 $41,821 7 payments
Fast $12,807 35 payments
PhIII Efficacy And Safety of RPC1063 in Relapsing MS (RPC01-3001) $6,540 1 payment
Relief $5,318 45 payments

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.